{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:56:13Z","timestamp":1792007773166,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.alit.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:51:53Z","timestamp":1778014313000},"page":"358-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rethinking interleukin-31: A neuroimmune orchestrator of itch beyond Th2 immunity"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5892-6138","authenticated-orcid":false,"given":"Hiroyuki","family":"Irie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0773-0554","authenticated-orcid":false,"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2026.04.004_bib1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaci.2005.10.046","article-title":"IL-31 is associated with cutaneous lymphocyte antigen-positive skin-homing T cells in patients with atopic dermatitis","volume":"117","author":"Bilsborough","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaci.2008.05.047","article-title":"Correlation of IL-31 serum levels with severity of atopic dermatitis","volume":"122","author":"Raap","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-0625.2010.01067.x","article-title":"Increased levels of serum IL-31 in chronic spontaneous urticaria","volume":"19","author":"Raap","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cea.12875","article-title":"Human basophils are a source of\u2014and are differentially activated by\u2014IL-31","volume":"47","author":"Raap","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2026.04.004_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jdermsci.2017.07.019","article-title":"Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgE","volume":"87","author":"Salz","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.alit.2026.04.004_bib8","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2340\/00015555-2951","article-title":"Eosinophils are a major source of interleukin-31 in bullous pemphigoid","volume":"98","author":"R\u00fcdrich","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2026.04.004_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/bjd.16498","article-title":"Itch in dermatomyositis: the role of increased skin interleukin-31","volume":"179","author":"Kim","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2340\/00015555-1345","article-title":"Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma","volume":"92","author":"Ohmatsu","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2026.04.004_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00403-014-1527-x","article-title":"Analysis of the IL-31 pathway in mycosis fungoides and S\u00e9zary syndrome","volume":"307","author":"Mobs","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.alit.2026.04.004_bib12","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/jid.2013.227","article-title":"IL-31 is produced by the malignant T-cell population in cutaneous T-cell lymphoma and correlates with CTCL pruritus","volume":"133","author":"Singer","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2014.08.004","article-title":"Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis","volume":"71","author":"Ko","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib14","article-title":"Elevated interleukin-31 serum levels in hemodialysis patients are associated with uremic pruritus","volume":"155","author":"Oweis","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.alit.2026.04.004_bib15","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1080\/14767058.2016.1205025","article-title":"Interleukin 31 is involved in intrahepatic cholestasis of pregnancy","volume":"30","author":"Basile","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.alit.2026.04.004_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.32599","article-title":"IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and are farnesoid X receptor responsive in NASH","volume":"77","author":"Xu","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.alit.2026.04.004_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2011.10.042","article-title":"IL-31 regulates differentiation and filaggrin expression in human organotypic skin models","volume":"129","author":"Cornelissen","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/exd.13697","article-title":"Effects of a ceramide-containing water-in-oil ointment on skin barrier function in an IL-31-treated 3D skin model","volume":"27","author":"Huth","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161877","article-title":"IL-31-driven skin remodeling involves epidermal cell proliferation and thickening that lead to impaired skin-barrier function","volume":"11","author":"Singh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2026.04.004_bib20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1398-9995.2009.02255.x","article-title":"Interleukin-31 induces pro-inflammatory cytokines in human monocytes and macrophages","volume":"65","author":"Kasraie","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.04.004_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/intimm\/dxq027","article-title":"Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis","volume":"22","author":"Cheung","year":"2010","journal-title":"Int Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib22","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.4049\/jimmunol.1101044","article-title":"Dendritic cells activated by IFN-\u03b3\/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment","volume":"188","author":"Horejs-Hoeck","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib23","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/ijms18071485","article-title":"Inflammatory and noninflammatory itch: implications in pathophysiology-directed treatments","volume":"18","author":"Wong","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2026.04.004_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijd.14081","article-title":"Itch and psyche: psychiatric aspects of pruritus","volume":"58","author":"Jafferany","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.alit.2026.04.004_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113433","article-title":"Sensory neuronal STAT3 is critical for IL-31 receptor expression and inflammatory itch","volume":"42","author":"Takahashi","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.alit.2026.04.004_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jaci.2013.03.050","article-title":"Human IL-31 is induced by IL-4 and promotes Th2-driven inflammation","volume":"132","author":"Stott","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1124018","article-title":"Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients","volume":"14","author":"Sans-de San Nicol\u00e0s","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib30","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.4049\/jimmunol.0900712","article-title":"Antimicrobial peptides induce secretion of a pruritogenic cytokine IL-31 by human mast cells","volume":"184","author":"Niyonsaba","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib31","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1182\/blood-2008-09-179416","article-title":"Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders","volume":"113","author":"Ishii","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.alit.2026.04.004_bib32","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/all.13870","article-title":"Pruritus in ordinary scabies: IL-31 from macrophages induced by TSLP and periostin","volume":"74","author":"Hashimoto","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.04.004_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2020.06.023","article-title":"TGF-\u03b2 induces interleukin-31 expression from dermal dendritic cells to stimulate wound itching","volume":"53","author":"Xu","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2026.04.004_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cytogfr.2015.07.006","article-title":"Oncostatin M and interleukin-31: cytokines, receptors, signal transduction and physiology","volume":"26","author":"Hermanns","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.alit.2026.04.004_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cytogfr.2008.08.003","article-title":"Structures and biological functions of IL-31 and IL-31 receptors","volume":"19","author":"Zhang","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.alit.2026.04.004_bib36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/09546634.2017.1290205","article-title":"Interleukin-31 pathway and its role in atopic dermatitis: a systematic review","volume":"28","author":"Saleem","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.alit.2026.04.004_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jdermsci.2014.02.009","article-title":"Distribution of IL-31 and its receptor-expressing cells in atopic dermatitis skin","volume":"74","author":"Kato","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.alit.2026.04.004_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.3881","article-title":"Unbiased classification of sensory neuron types by single-cell RNA sequencing","volume":"18","author":"Usoskin","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.alit.2026.04.004_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.71752","article-title":"Single-nucleus transcriptomic analysis of human dorsal root ganglion neurons","volume":"10","author":"Nguyen","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.alit.2026.04.004_bib40","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/s41467-021-21725-z","article-title":"Single cell transcriptomics of primate sensory neurons identifies cell types associated with chronic pain","volume":"12","author":"Kupari","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.alit.2026.04.004_bib41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41467-023-36014-0","article-title":"Cross-species transcriptomic atlas of dorsal root ganglia reveals species-specific programs for sensory function","volume":"14","author":"Jung","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.alit.2026.04.004_bib42","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/s41593-024-01794-1","article-title":"Leveraging deep single-soma RNA sequencing to explore the neural basis of human somatosensation","volume":"27","author":"Yu","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.alit.2026.04.004_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/exd.12587","article-title":"Repeated administration of IL-31 upregulates IL-31 receptor A (IL-31RA) in dorsal root ganglia and causes severe itch-associated scratching behaviour in mice","volume":"24","author":"Arai","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib44","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/ijms24021047","article-title":"Interleukin-31 receptor A expression in the dorsal root ganglion of mice with atopic dermatitis","volume":"24","author":"Arai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2026.04.004_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1251031","article-title":"Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching","volume":"14","author":"Suehiro","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib46","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jaci.2017.12.1002","article-title":"New mechanism underlying IL-31\u2013induced atopic dermatitis","volume":"141","author":"Meng","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.15252\/embr.201540983","article-title":"A subpopulation of itch-sensing neurons marked by somatostatin expression","volume":"17","author":"Stantcheva","year":"2016","journal-title":"EMBO Rep"},{"key":"10.1016\/j.alit.2026.04.004_bib48","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jaci.2019.06.031","article-title":"Selective role of neurokinin B in IL-31\u2013induced itch","volume":"144","author":"Sakata","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/jir.2007.0057","article-title":"Regulated expression of the IL-31 receptor in pulmonary cells","volume":"28","author":"Jawa","year":"2008","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.alit.2026.04.004_bib50","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2567.2007.02668.x","article-title":"IL-31 induces cytokine production from bronchial epithelial cells","volume":"122","author":"Ip","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.alit.2026.04.004_bib51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1398-9995.2007.01566.x","article-title":"SCF and IL-31 as indicators in allergic asthma","volume":"63","author":"Lei","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.04.004_bib52","article-title":"IL-31 expression and disease severity in asthma","volume":"6","author":"Lai","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2026.04.004_bib53","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/gut.2006.118679","article-title":"IL-31 mediates signaling in intestinal epithelial cells","volume":"56","author":"Dambacher","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.alit.2026.04.004_bib54","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/14728222.2019.1677608","article-title":"Oncostatin M as a therapeutic target in IBD","volume":"23","author":"Verstockt","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.alit.2026.04.004_bib55","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3390\/ijms21041239","article-title":"IL-33\/IL-31 axis in osteoporosis","volume":"21","author":"De Martinis","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2026.04.004_bib56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12865-015-0125-9","article-title":"Increased IL-31 levels in osteoporosis","volume":"16","author":"Ginaldi","year":"2015","journal-title":"BMC Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib57","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.3389\/fimmu.2019.02666","article-title":"Cytokines and bone markers in postmenopausal women","volume":"10","author":"Mannucci","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/vde.12364","article-title":"Safety of lokivetmab in dogs with atopic dermatitis","volume":"27","author":"Michels","year":"2016","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib59","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/vde.12682","article-title":"Lokivetmab for allergic pruritus in dogs","volume":"29","author":"Souza","year":"2018","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.24425\/pjvs.2020.132765","article-title":"Clinical efficiency of lokivetmab in dogs","volume":"23","author":"Szczepanik","year":"2020","journal-title":"Pol J Vet Sci"},{"key":"10.1016\/j.alit.2026.04.004_bib61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/vde.12702","article-title":"Lokivetmab therapy for mastocytosis-associated pruritus","volume":"30","author":"Meichner","year":"2019","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/exd.13236","article-title":"Cynomolgus monkey model of IL-31-induced scratching","volume":"27","author":"Oyama","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib63","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.vetimm.2009.03.014","article-title":"Molecular cloning of canine IL-31","volume":"131","author":"Mizuno","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.alit.2026.04.004_bib64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa1917006","article-title":"Trial of nemolizumab for atopic dermatitis with pruritus","volume":"383","author":"Kabashima","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.alit.2026.04.004_bib65","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(24)01203-0","article-title":"Nemolizumab in atopic dermatitis: ARCADIA 1 and 2 trials","volume":"404","author":"Silverberg","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2026.04.004_bib66","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","article-title":"Phase 3 trial of nemolizumab in prurigo nodularis","volume":"389","author":"Kwatra","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.alit.2026.04.004_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jamadermatol.2024.4796","article-title":"Nemolizumab in prurigo nodularis: OLYMPIA 1 trial","volume":"161","author":"St\u00e4nder","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib68","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.20873","article-title":"Long-term nemolizumab therapy in atopic dermatitis","volume":"186","author":"Kabashima","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib69","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/bjd\/ljae458","article-title":"Long-term nemolizumab in pediatric atopic dermatitis","volume":"192","author":"Igarashi","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib70","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/bjd\/ljaf045","article-title":"Long-term nemolizumab in prurigo nodularis","volume":"193","author":"Yokozeki","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib71","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1084\/jem.20061791","article-title":"IL-31\u2013IL-31R interactions negatively regulate lung inflammation","volume":"204","author":"Perrigoue","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.alit.2026.04.004_bib72","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.4049\/jimmunol.0802459","article-title":"IL-31 limits Th2-dependent immunity in helminth infection","volume":"182","author":"Perrigoue","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib73","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/eji.202048547","article-title":"IL-31 transgenic mice show reduced lung inflammation","volume":"51","author":"Neuper","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib74","doi-asserted-by":"crossref","first-page":"eabi6887","DOI":"10.1126\/sciimmunol.abi6887","article-title":"IL-31-dependent neurogenic inflammation restrains type 2 immunity","volume":"8","author":"Fassett","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2026.02.044","article-title":"IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene-related peptide\u2013calcitonin receptor-like neuroimmune suppression in atopic dermatitis","author":"Honryo","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib76","article-title":"Vixarelimab in prurigo nodularis","volume":"161","author":"St\u00e4nder","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib77","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJMoa2019380","article-title":"Abrocitinib versus placebo or dupilumab for atopic dermatitis","volume":"384","author":"Bieber","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.alit.2026.04.004_bib78","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archdermatol.2011.178","article-title":"Impact of pruritus on quality of life","volume":"147","author":"Kini","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib79","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jid.2020.03.488","article-title":"Quality of life and economic burden of chronic pruritus","volume":"140","author":"Whang","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib80","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden in atopic dermatitis","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2026.04.004_bib81","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jid.2019.07.711","article-title":"Annual health care costs of chronic pruritus","volume":"140","author":"Luk","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.alit.2026.04.004_bib82","first-page":"9","article-title":"Annual cost of care for atopic dermatitis in Mexico","volume":"67","author":"Guevara-Sangines","year":"2020","journal-title":"Rev Alerg Mex"},{"key":"10.1016\/j.alit.2026.04.004_bib83","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaad.2020.06.1002","article-title":"Emergency department utilization in prurigo nodularis","volume":"84","author":"Whang","year":"2021","journal-title":"J Am Acad Dermatol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S132389302600047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S132389302600047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:05:51Z","timestamp":1781309151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S132389302600047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S132389302600047X"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2026.04.004","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking interleukin-31: A neuroimmune orchestrator of itch beyond Th2 immunity","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}